4-Methylsulfonylbenzylamine hydrochloride → N-(4-(Methylsulfonyl)benzyl)-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxamide

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	4-Methylsulfonylbenzylamine hydrochloride	HCID 2729269	—
Edukt	Lithium 7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxylate	HCID 68787401	—
Produkt	N-(4-(Methylsulfonyl)benzyl)-7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxamide	HCID 59636750	—

Reaktionsschritte

The compound was prepared according to the procedure disclosed in Example 1 starting from lithium 7-(4-(2-(pyridin-2-yl)ethyl)piperazin-1-yl)benzofuran-2-carboxylate (60 mg, 0.16 mmol) and 4-methylsulphonylbenzylamine hydrochloride (42 mg, 0.19 mmol). Yield: 38 mg (43%).

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US08367676B2
Quelldatensatz	uspto-grants-2013_02
ORD ID	ord-5eb23c79a201478184af04b52207ad4d
Quellennotiz	uspto-grants-2013_02